Global Medical Expert: Dr. Jennifer A. Doudna
- Global Research Partnerships
- May 24
- 1 min read
Nobel Laureate in Chemistry (2020) | Professor at UC Berkeley | Co-inventor of CRISPR-Cas9
Dr. Jennifer Doudna is a Nobel Laureate in Chemistry and Professor of Biochemistry, Biophysics and Structural Biology at UC Berkeley. Her groundbreaking research focuses on RNA biology and led to the discovery of CRISPR-Cas9 as a revolutionary genome editing tool. She received the 2020 Nobel Prize in Chemistry alongside Emmanuelle Charpentier for developing CRISPR-Cas9, a technology that allows scientists to make precise edits to DNA with unprecedented accuracy.
Born in 1964, Doudna has transformed the course of genomics research and medicine. Her work has enabled the development of the first CRISPR-based therapies, including treatments for sickle cell disease. She is committed to making gene editing accessible and affordable globally, focusing on developing in vivo delivery methods that could revolutionize treatment accessibility.
Currently, Doudna serves as the Li Ka Shing Chancellor's Chair at UC Berkeley and is the founder and leader of the Innovative Genomics Institute. Her recent research focuses on precision genome editing delivery systems, including the development of novel nanoparticle delivery methods and the exploration of CRISPR applications in microbiome editing.
Notable Recent Achievements
Led research that enabled the FDA approval of Casgevy, the first CRISPR-based therapy for sickle cell disease in December 2023
Received the National Medal of Technology and Innovation in 2025
Pioneering precision microbiome editing through her work at the Innovative Genomics Institute
